U.S. markets closed
  • S&P 500

    3,269.96
    -40.15 (-1.21%)
     
  • Dow 30

    26,501.60
    -157.51 (-0.59%)
     
  • Nasdaq

    10,911.59
    -274.00 (-2.45%)
     
  • Russell 2000

    1,538.48
    -23.10 (-1.48%)
     
  • Crude Oil

    35.72
    -0.45 (-1.24%)
     
  • Gold

    1,878.80
    +10.80 (+0.58%)
     
  • Silver

    23.72
    +0.35 (+1.52%)
     
  • EUR/USD

    1.1641
    -0.0037 (-0.31%)
     
  • 10-Yr Bond

    0.8600
    +0.0250 (+2.99%)
     
  • GBP/USD

    1.2953
    +0.0030 (+0.23%)
     
  • USD/JPY

    104.6350
    +0.0250 (+0.02%)
     
  • BTC-USD

    13,833.24
    +6.93 (+0.05%)
     
  • CMC Crypto 200

    265.42
    +1.78 (+0.68%)
     
  • FTSE 100

    5,577.27
    -4.48 (-0.08%)
     
  • Nikkei 225

    22,977.13
    -354.81 (-1.52%)
     

Moderna Inc (MRNA) CEO Stephane Bancel Sold $1.4 million of Shares

GuruFocus.com
·2 mins read

- By insider

CEO of Moderna Inc (30-Year Financial, Insider Trades) Stephane Bancel (insider trades) sold 19,000 shares of MRNA on 10/08/2020 at an average price of $72.42 a share. The total sale was $1.4 million.


Moderna Inc has a market cap of $28.8 billion; its shares were traded at around $73.00 with and P/S ratio of 250.01. GuruFocus has detected 1 severe warning sign with Moderna Inc. .

CEO Recent Trades:

  • CEO Stephane Bancel sold 19,000 shares of MRNA stock on 10/08/2020 at the average price of $72.42. The price of the stock has increased by 0.8% since.

  • CEO Stephane Bancel sold 11,046 shares of MRNA stock on 10/02/2020 at the average price of $70.64. The price of the stock has increased by 3.34% since.

  • CEO Stephane Bancel sold 27,481 shares of MRNA stock on 10/01/2020 at the average price of $70.6. The price of the stock has increased by 3.4% since.

  • CEO Stephane Bancel sold 11,046 shares of MRNA stock on 09/25/2020 at the average price of $68.49. The price of the stock has increased by 6.58% since.

  • CEO Stephane Bancel sold 19,000 shares of MRNA stock on 09/24/2020 at the average price of $66.68. The price of the stock has increased by 9.48% since.

Directors and Officers Recent Trades:

  • Chief Medical Officer Tal Zvi Zaks sold 15,000 shares of MRNA stock on 10/05/2020 at the average price of $70.24. The price of the stock has increased by 3.93% since.

  • President Stephen Hoge sold 20,000 shares of MRNA stock on 10/05/2020 at the average price of $68.68. The price of the stock has increased by 6.29% since.

  • Chief Medical Officer Tal Zvi Zaks sold 17,197 shares of MRNA stock on 09/28/2020 at the average price of $70.28. The price of the stock has increased by 3.87% since.

  • President Stephen Hoge sold 20,000 shares of MRNA stock on 09/24/2020 at the average price of $66.72. The price of the stock has increased by 9.41% since.

  • Chief Medical Officer Tal Zvi Zaks sold 20,000 shares of MRNA stock on 09/21/2020 at the average price of $67.3. The price of the stock has increased by 8.47% since.

For the complete insider trading history of MRNA, click here

.This article first appeared on GuruFocus.